Evidence map›Paper›PMID 34667076›Full record

ArticleCMAJ open

Changes in the reach of a smoking cessation program in Ontario, Canada, during the COVID-19 pandemic: a cross-sectional study.

Nadia Minian, Scott Veldhuizen, Elise Tanzini, Stephanie Duench, Wayne K deRuiter, Megan Barker, Laurie Zawertailo, Osnat C Melamed, Peter Selby

Abstract read
In one paragraph

Article in CMAJ open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Utilization of mental health services during the first year of the COVID-19 pandemic - a systematic review and meta-analysis.European psychiatry : the journal of the Association of European Psychiatrists · 2026
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Roles, experiences and perspectives of the stakeholders of "10,000 Lives" smoking cessation initiative in Central Queensland: Findings from an online survey during COVID-19 situation.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nadia MinianNicotine Dependence Service (Minian, Veldhuizen, Tanzini, Duench, deRuiter, Barker, Zawertailo, Melamed, Selby), Centre for Addiction and Mental Health; Department of Family and Community Medicine (Minian), and Dalla Lana School of Public Health (Barker), and Department of Pharmacology and Toxicology (Zawertailo), Faculty of Medicine, and Department of Family and Community Medicine (Melamed, Selby), University of Toronto, Toronto, Ont.
Scott VeldhuizenNicotine Dependence Service (Minian, Veldhuizen, Tanzini, Duench, deRuiter, Barker, Zawertailo, Melamed, Selby), Centre for Addiction and Mental Health; Department of Family and Community Medicine (Minian), and Dalla Lana School of Public Health (Barker), and Department of Pharmacology and Toxicology (Zawertailo), Faculty of Medicine, and Department of Family and Community Medicine (Melamed, Selby), University of Toronto, Toronto, Ont.
Elise TanziniNicotine Dependence Service (Minian, Veldhuizen, Tanzini, Duench, deRuiter, Barker, Zawertailo, Melamed, Selby), Centre for Addiction and Mental Health; Department of Family and Community Medicine (Minian), and Dalla Lana School of Public Health (Barker), and Department of Pharmacology and Toxicology (Zawertailo), Faculty of Medicine, and Department of Family and Community Medicine (Melamed, Selby), University of Toronto, Toronto, Ont.
Stephanie DuenchNicotine Dependence Service (Minian, Veldhuizen, Tanzini, Duench, deRuiter, Barker, Zawertailo, Melamed, Selby), Centre for Addiction and Mental Health; Department of Family and Community Medicine (Minian), and Dalla Lana School of Public Health (Barker), and Department of Pharmacology and Toxicology (Zawertailo), Faculty of Medicine, and Department of Family and Community Medicine (Melamed, Selby), University of Toronto, Toronto, Ont.
Wayne K deRuiterNicotine Dependence Service (Minian, Veldhuizen, Tanzini, Duench, deRuiter, Barker, Zawertailo, Melamed, Selby), Centre for Addiction and Mental Health; Department of Family and Community Medicine (Minian), and Dalla Lana School of Public Health (Barker), and Department of Pharmacology and Toxicology (Zawertailo), Faculty of Medicine, and Department of Family and Community Medicine (Melamed, Selby), University of Toronto, Toronto, Ont.
Megan BarkerNicotine Dependence Service (Minian, Veldhuizen, Tanzini, Duench, deRuiter, Barker, Zawertailo, Melamed, Selby), Centre for Addiction and Mental Health; Department of Family and Community Medicine (Minian), and Dalla Lana School of Public Health (Barker), and Department of Pharmacology and Toxicology (Zawertailo), Faculty of Medicine, and Department of Family and Community Medicine (Melamed, Selby), University of Toronto, Toronto, Ont.
Laurie ZawertailoNicotine Dependence Service (Minian, Veldhuizen, Tanzini, Duench, deRuiter, Barker, Zawertailo, Melamed, Selby), Centre for Addiction and Mental Health; Department of Family and Community Medicine (Minian), and Dalla Lana School of Public Health (Barker), and Department of Pharmacology and Toxicology (Zawertailo), Faculty of Medicine, and Department of Family and Community Medicine (Melamed, Selby), University of Toronto, Toronto, Ont.
Osnat C MelamedNicotine Dependence Service (Minian, Veldhuizen, Tanzini, Duench, deRuiter, Barker, Zawertailo, Melamed, Selby), Centre for Addiction and Mental Health; Department of Family and Community Medicine (Minian), and Dalla Lana School of Public Health (Barker), and Department of Pharmacology and Toxicology (Zawertailo), Faculty of Medicine, and Department of Family and Community Medicine (Melamed, Selby), University of Toronto, Toronto, Ont.
Peter SelbyNicotine Dependence Service (Minian, Veldhuizen, Tanzini, Duench, deRuiter, Barker, Zawertailo, Melamed, Selby), Centre for Addiction and Mental Health; Department of Family and Community Medicine (Minian), and Dalla Lana School of Public Health (Barker), and Department of Pharmacology and Toxicology (Zawertailo), Faculty of Medicine, and Department of Family and Community Medicine (Melamed, Selby), University of Toronto, Toronto, Ont. peter.selby@camh.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGiven the harms associated with tobacco use, continuing the provision of smoking cessation treatment during the COVID-19 pandemic is critical. The aim of this study was to examine pandemic-related changes in enrolment, total treatment use and participant characteristics in a large, publicly funded smoking cessation program in Ontario, Canada.

methodsWe conducted a secondary data analysis of patients who enrolled in the program between Jan. 1, 2018, and Dec. 7, 2020. We used descriptive statistics to examine changes in treatment use. To test for differences in sociodemographic and health variables, we used segmented mixed-effects regression with a break point on Mar. 17, 2020, when Ontario declared a state of emergency. We tested 25 variables, using Holm's correction for multiplicity.

resultsWe analyzed 60 373 enrolments. In the month after the break point, enrolments fell 69% and total visits fell 42% relative to previous years. After Mar. 17, 2020, those who enrolled were less likely to report employment in the previous week (absolute expected difference -12.4%, 95% confidence interval [CI] -15.0% to -9.8%); were more likely to be occasional (1.3%, 95% CI 0.6% to 1.9%) or noncurrent smokers (1.7%, 95% CI 0.8% to 2.6%); were less likely to have set a target quit date (-4.8%, 95% CI -7.0% to -2.6%); and were more likely to have a physical health (6.6%, 95% CI 4.0% to 9.2%), mental health (4.6%, 95% CI 1.9% to 7.2%) or substance use diagnosis (3.5%, 95% CI 1.3% to 5.6%).

interpretationSharp decreases in new enrolments and subsequent visits to smoking cessation programs were seen when pandemic restrictions were implemented in Ontario, but the characteristics of the people who accessed the programs did not change markedly. Incorporating an equity perspective is essential when new models of care for smoking cessation are developed.

Indexed as

AdultAgedCOVID-19Cross-Sectional StudiesFemaleHumansMaleMental HealthMiddle AgedOntarioSARS-CoV-2SmokersSmokingSmoking CessationSmoking PreventionSubstance-Related Disorders

Identifiers

PMID34667076
PMCPMC8526090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.